Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Bedfont Scientific, Ltd.
WARNING LETTER
•Bedfont Scientific, Ltd.•October 31, 2019

Bedfont Scientific, Ltd. – FDA Warning Letter, Oct 31, 2019

Record Details

An FDA inspection conducted from October 28-31, 2019, at a firm in Maidstone, Kent, United Kingdom, manufacturing carbon monoxide gas analyzers, revealed significant violations of the Quality System (QS) regulation (21 CFR Part 820). The devices were deemed adulterated under section 501(h) of the Federal Food, Drug, and Cosmetic Act. The firm's response dated November 20, 2019, was found inadequate, lacking sufficient documentation and timelines for proposed corrective actions. Key violations include: 1) Failure to establish and maintain procedures for device design validation (21 CFR 820.30(g)), with issues like validation on non-initial production units and inadequate software change documentation. 2) Failure to establish and maintain corrective and preventive action (CAPA) procedures (21 CFR 820.100(a)), evidenced by inadequate quality data analysis, closed CAPAs without effectiveness verification, and unaddressed supplier issues. 3) Failure to control non-conforming product (21 CFR 820.90(a)), as products failing tests were released without proper review. 4) Failure to ensure inspection, measuring, and test equipment suitability (21 CFR 820.72(a)), including lack of calibration procedures for flow meters and no assessment of product impact from out-of-calibration equipment. 5) Failure to establish and conduct quality audits (21 CFR 820.22), with numerous quality system areas not audited in 2017 and 2018. The FDA requires a written response within fifteen business days detailing specific corrections, preventive actions, documentation, and a timetable. Failure to comply could impact federal contracts, Class III device approvals, and the issuance of Certificates to Foreign Governments. The letter stresses that these violations may indicate systemic quality management problems requiring thorough investigation.

Company
Bedfont Scientific, Ltd.
Inspection date
October 31, 2019
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Jason Aversano
  • Malvina B. Eydelman (Office Director)
View Company Profile

ID · 3eac080e-34a4-497e-82f7-fcad568e6b8a

Violation Codes8
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.30(g)21 CFR 820.100(a)21 CFR 820.90(a)21 CFR 820.72(a)21 CFR 820.22

Full citation text and observation details available on the Dashboard.

Other documents for Bedfont Scientific, Ltd.
  • 483 - 2019-10-31October 31, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bedfont Scientific, Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.